Broadfin Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Broadfin Capital’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-647,500	Closed	-$23.5M	–	63
2016 Q4	$23.5M	Buy	647,500 +347,500	+116%	+$13.9M	2.61%	12
2016 Q3	$13.8M	Buy	+300,000	New	+$15.7M	1.24%	24
2014 Q2	–	Sell	-291,636	Closed	-$14.9M	–	79
2014 Q1	$15.4M	Sell	291,636 -550,100	-65%	-$25.4M	1.49%	23
2013 Q4	$33.7M	Buy	841,736 +200,000	+31%	+$7.88M	4.45%	4
2013 Q3	$24.2M	Sell	641,736 -221,500	-26%	-$8.64M	4.3%	7
2013 Q2	$33.8M	Buy	+863,236	New	+$33.6M	6.62%	2

Other funds holding TEVA

Capital Research Global Investors

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return